Citations

Mayo Clinic

Showing 10 of 108572 citations.

Power of pleomorphic parakeratosis
Agrawal, Shruti , Neal, Donald, Lehman, Julia S. , Neal, Donald E, Lehman, Julia S , Tekin, Burak

Journal of Cutaneous Pathology | December 21, 2023 | Volume: 51 | Issue: 5 | Pages: 327-328

10.1111/cup.14580 | PMID 38126159 Get It

Whole Blood Reactivity to Viral and Bacterial Pathogens after Non-Emergent Cardiac Surgery during the Acute and Convalescence Periods Demonstrates a Distinctive Profile of Cytokines Production Compared to the Preoperative Baseline in Cohort of 108 Patients
Laudański, Krzysztof , Liu, Da , Karnatovskaia, Lioudmila V. , Devang, Sanghavi, Mathew, Amal , Szeto, Wilson Y. , Karnatovskaia, Lioudmila

Biomedicines | December 21, 2023 | Volume: 12 | Issue: 1 | Pages: 28

10.3390/biomedicines12010028 | PMID 38275389 Get It

The release of danger signals from tissues in response to trauma during cardiac surgery creates conditions to reprogram the immune system to subsequent challenges posed by pathogens in the postoperative period. To demonstrate this, we tested immunoreactivity before surgery as the baseline (tbaseline), followed by subsequent challenges during the acute phase (t24h), convalescence (t7d), and long-term recovery (t3m). For 108 patients undergoing elective heart surgery, whole blood was stimulated with lipopolysaccharide (LPS), Influenza A virus subtype N2 (H3N2), or the Flublok™ vaccine to represent common pathogenic challenges. Leukocytosis, platelet count, and serum C-reactive protein (CRP) were used to measure non-specific inflammation. Cytokines were measured after 18 h of stimulation to reflect activation of the various cell types (activated neutrophils–IL-8; activated T cells-IL-2, IFNγ, activated monocyte (MO)-TNFα, IL-6, and deactivated or atypically activated MO and/or T cells–M-CSF, IL-10). IL-2 and IL-10 were increased at t7d, while TNFα was suppressed at t24h when LPS was utilized. Interestingly, M-CSF and IL-6 production was elevated at seven days in response to all stimuli compared to baseline. While some non-specific markers of inflammation (white cell count, IL-6, and IL-8) returned to presurgical levels at t3m, CRP and platelet counts remained elevated. We showed that surgical stimulus reprograms leukocyte response to LPS with only partial restoration of non-specific markers of inflammation.
Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk
Tunold, Jon‐Anders, Toft, Mathias , Ross, Owen A. , Pihlstrøm, Lasse , Ross, Owen A , Pihlstrøm, Lasse , Toft, Mathias , Tan, Manuela , Berg, Wilma D. J. van de

Movement Disorders | December 21, 2023 | Volume: 39 | Issue: 3 | Pages: 596-601

10.1002/mds.29698 | PMID 38124396 Get It

AbstractBackgroundGenetics influence cognitive progression in Parkinson's disease, possibly through mechanisms related to Lewy and Alzheimer's disease pathology. Lysosomal polygenic burden has recently been linked to more severe Lewy pathology post mortem.ObjectivesTo assess the influence of lysosomal polygenic burden on cognitive progression in Parkinson's disease patients with low Alzheimer's disease risk.MethodsUsing Cox regression we assessed association between lysosomal polygenic scores and time to Montreal Cognitive Assessment score ≤ 21 in the Parkinson's Progression Markers Initiative cohort (n = 374), with replication in data from the Parkinson's Disease Biomarker Program (n = 777). Patients were stratified by Alzheimer's disease polygenic risk.ResultsThe lysosomal polygenic score was associated with faster progression of cognitive decline in patients with low Alzheimer's disease risk in both datasets (P = 0.0032 and P = 0.0054, respectively).ConclusionOur study supports complex interplay between genetics and neuropathology in Parkinson's disease‐related cognitive impairment, emphasizing the role of lysosomal polygenic burden. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors
Alexander, S P H , Fabbro, Doriano , Mathie, Alistair , Peters, John A. , Veale, Emma L. , Armstrong, Jane F , Faccenda, Elena , Harding, Simon D , Davies, Jamie A. , Beuve, Annie , Brouckaert, Peter, Burnett, John C. , Friebe, Andreas , Garthwaite, John , Koesling, Doris , Kühn, Michaela , Potter, Lincoln R. , Stasch, Johannes‐Peter, Alexander, Stephen P H , Mathie, Alistair A , Peters, John A , Veale, Emma L , Armstrong, Jane F , Faccenda, Elena , Harding, Simon D , Davies, Jamie A , Bryant, Clare , Farndale, Richard W , Jarvis, Gavin E , MacEwan, David , Monie, Tom P , Kelly, Eamonn , Hobbs, Adrian J , Russwurm, Michael , Schmidt, Harald , Waldman, Scott A.

British Journal of Pharmacology | December 21, 2023 | Volume: 180 | Issue: S2 | Pages: No page available

10.1111/bph.16180 | PMID 38123155 Get It

The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and nearly 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (https://www.guidetopharmacology.org/), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.16180. Catalytic receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ion channels, nuclear hormone receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
Evidence-Based Commentary: Testing for Clostridioides difficile Infection
Khanna, Sahil

Journal of Gastrointestinal Infections | December 20, 2023 | Volume: 13 | Issue: 02 | Pages: 095-098

10.1055/s-0043-1777090 Get It

Cough: An Introductory Guide for Speech-Language Pathologists
Novaleski, Carolyn K. , Near, Lucille A., Benzo, Roberto P.

Perspectives of the ASHA Special Interest Groups | December 20, 2023 | Volume: 9 | Issue: 1 | Pages: 75-91

10.1044/2023_persp-23-00203 Get It

Purpose: The airway defense mechanism of cough is essential for human survival. Recognition is growing about the distinct role of speech-language pathologists in the nonpharmacological management of various cough disorders. This clinical focus article aims to deliver relevant education about normal and pathological cough to strengthen existing clinical knowledge and skills. Conclusions: The neuronal pathways underlying normal cough function are complex. Cough problems refer to either reduced or heightened cough stemming from various disease processes, and both clinical presentations have detrimental consequences. Current evidence supports that patients who suffer from cough dysfunction benefit from nonpharmacological interventions offered via speech therapy as an adjunct to medical treatments. Speech therapy strategies apply the higher cognitive components of cough by focusing on the deliberate modification and coordination of respiration. Future research priorities are positioned toward improving clinical outcomes for cough disorders.
Gynecomastia in a Man With Adrenal Mass
Saini, Jasmine , Navin, Patrick J. , Rivera, Michael , Navin, Patrick , Bancos, Irina , Saini, Jasmine , Bancos, Irina

JCEM Case Reports | December 20, 2023 | Volume: 2 | Issue: 1 | Pages: No page available

10.1210/jcemcr/luad143 | PMID 38192879 Get It

Abstract Estrogen-secreting adrenocortical carcinoma (ACC) is exceedingly rare, representing 1% to 2% of all ACCs. We present a case of a 65-year-old man diagnosed with an estrogen-secreting, 4.3-cm right adrenal mass discovered during work-up for bilateral gynecomastia. Gynecomastia and hyperestrogenism resolved after laparoscopic adrenalectomy, and pathology was reported as adrenocortical adenoma. However, 5 years later, he again developed bilateral gynecomastia because of recurrent hyperestrogenism. Imaging revealed multiple metastases in the abdomen. Urine steroid profiling demonstrated increased androgen precursors, androgen metabolites, and glucocorticoid precursors. Ultrasound-guided biopsy of one of the metastases confirmed ACC. Initial therapy included debulking surgery with removal of metastatic lesions. Mitotane therapy was initiated 4 weeks later along with hydrocortisone for anticipated mitotane-induced adrenal insufficiency. Histopathology from the adrenalectomy specimen 5 years earlier was rereviewed and confirmed ACC. Estrogen-secreting adrenal tumors are exceedingly rare, and the majority are malignant. This case underlines the importance of making an initial accurate diagnosis of adrenal malignancy that allows better surgical planning and appropriate monitoring. Indeterminate imaging characteristics of the adrenal mass, as well as the presentation with estrogen excess, suggested an elevated risk for ACC. Initial pathology-based misdiagnosis illustrates the need for an expert adrenal pathologist to review these rare tumors.
Reply by Authors
Tyson, Mark D. , Abouassaly, Robert , Durant, Adri , Smith, Antonia Bosworth , Seemann, K. , Shoskes, Daniel A.

Urology Practice | December 20, 2023 | Volume: 11 | Issue: 1 | Pages: 60-60

10.1097/upj.0000000000000489.02 | PMID 38117970 Get It

Editorial Comment
Britton, Cameron J. , Koo, Kevin

Urology Practice | December 20, 2023 | Volume: 11 | Issue: 1 | Pages: 132-133

10.1097/upj.0000000000000478.01 | PMID 38117974 Get It